208 related articles for article (PubMed ID: 30318288)
1. Utility of
Wang Z; Mao Z; Zhang X; He D; Wang X; Du Q; Xiao Z; Zhu D; Zhu Y; Wang H
Acad Radiol; 2019 Sep; 26(9):1222-1228. PubMed ID: 30318288
[TBL] [Abstract][Full Text] [Related]
2. Clinical application of combination [
Wang Z; Feng Z; Zhu D; Wang X; Chen J; Zhu Y; Wang H
BMC Endocr Disord; 2024 Feb; 24(1):19. PubMed ID: 38311763
[TBL] [Abstract][Full Text] [Related]
3. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR
J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
[TBL] [Abstract][Full Text] [Related]
4. Utility of 11C-Methionine and 18F-FDG PET/CT in Patients With Functioning Pituitary Adenomas.
Feng Z; He D; Mao Z; Wang Z; Zhu Y; Zhang X; Wang H
Clin Nucl Med; 2016 Mar; 41(3):e130-4. PubMed ID: 26646998
[TBL] [Abstract][Full Text] [Related]
5. Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions.
Seok H; Lee EY; Choe EY; Yang WI; Kim JY; Shin DY; Cho HJ; Kim TS; Yun MJ; Lee JD; Lee EJ; Lim SK; Rhee Y
Korean J Intern Med; 2013 Jan; 28(1):81-8. PubMed ID: 23346000
[TBL] [Abstract][Full Text] [Related]
6. Comparison of MRI techniques for detecting microadenomas in Cushing's disease.
Grober Y; Grober H; Wintermark M; Jane JA; Oldfield EH
J Neurosurg; 2018 Apr; 128(4):1051-1057. PubMed ID: 28452619
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of suprasellar meningiomas from non-functioning pituitary macroadenomas by
Ding L; Zhang F; He Q; Li Z; Shi X; Li R; Zhang X
BMC Cancer; 2020 Jun; 20(1):564. PubMed ID: 32552842
[TBL] [Abstract][Full Text] [Related]
8. PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study.
Wang H; Hou B; Lu L; Feng M; Zang J; Yao S; Feng F; Wang R; Li F; Zhu Z
J Nucl Med; 2018 Mar; 59(3):523-528. PubMed ID: 28775202
[TBL] [Abstract][Full Text] [Related]
9. A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndrome.
Koulouri O; Steuwe A; Gillett D; Hoole AC; Powlson AS; Donnelly NA; Burnet NG; Antoun NM; Cheow H; Mannion RJ; Pickard JD; Gurnell M
Eur J Endocrinol; 2015 Oct; 173(4):M107-20. PubMed ID: 26245763
[TBL] [Abstract][Full Text] [Related]
10. CRH stimulation improves
Boyle J; Patronas NJ; Smirniotopoulos J; Herscovitch P; Dieckman W; Millo C; Maric D; Chatain GP; Hayes CP; Benzo S; Scott G; Edwards N; Ray Chaudhury A; Lodish MB; Sharma S; Nieman LK; Stratakis CA; Lonser RR; Chittiboina P
Endocrine; 2019 Jul; 65(1):155-165. PubMed ID: 31062234
[TBL] [Abstract][Full Text] [Related]
11. The pituitary in nuclear medicine imaging.
Iglesias P; Cardona J; Díez JJ
Eur J Intern Med; 2019 Oct; 68():6-12. PubMed ID: 31519379
[TBL] [Abstract][Full Text] [Related]
12. Pituitary magnetic resonance imaging in Cushing's disease.
Vitale G; Tortora F; Baldelli R; Cocchiara F; Paragliola RM; Sbardella E; Simeoli C; Caranci F; Pivonello R; Colao A;
Endocrine; 2017 Mar; 55(3):691-696. PubMed ID: 27435590
[TBL] [Abstract][Full Text] [Related]
13. All that glitters on PET is not cancer! 18F-deoxy-glucose avidity versus tumor biology: pituitary incidentaloma in a survivor of two previous unrelated malignancies.
Miljić D; Manojlović-Gačić E; Skender-Gazibara M; Milojević T; Bogosavljević V; Kozarević N; Petrović N; Stojanović M; Pekić S; Doknić M; Petakov M; Popović V
Endokrynol Pol; 2017; 68(3):352-359. PubMed ID: 28660992
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of three-Tesla magnetic resonance imaging for the identification of pituitary adenoma in patients with Cushing's disease.
Fukuhara N; Inoshita N; Yamaguchi-Okada M; Tatsushima K; Takeshita A; Ito J; Takeuchi Y; Yamada S; Nishioka H
Endocr J; 2019 Mar; 66(3):259-264. PubMed ID: 30760659
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients.
Lampropoulos KI; Samonis G; Nomikos P
Hormones (Athens); 2013; 12(2):254-64. PubMed ID: 23933694
[TBL] [Abstract][Full Text] [Related]
16. Comparison of (68)Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidal adenomectomy.
Zhao X; Xiao J; Xing B; Wang R; Zhu Z; Li F
Clin Nucl Med; 2014 Jul; 39(7):605-8. PubMed ID: 24873787
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of fused positron emission tomography/computed tomography in the localization of adrenocorticotropin-secreting pituitary adenoma in Cushing's disease.
Alzahrani AS; Farhat R; Al-Arifi A; Al-Kahtani N; Kanaan I; Abouzied M
Pituitary; 2009; 12(4):309-14. PubMed ID: 19387839
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone suppression for
Kim K; Kim DK; Moon JH; Kim EH; Kim SH; Ku CR; Lee EJ
Cancer Imaging; 2023 Sep; 23(1):85. PubMed ID: 37700359
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
20. FDG PET/CT Findings of Ectopic Pituitary Adenoma.
Ishizaki U; Abe K; Takako K; Masui K; Sakai S
Clin Nucl Med; 2020 Feb; 45(2):151-153. PubMed ID: 31876824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
